Instruct-ERIC has years of experience in collaborating with industry researchers, from the Biotech, Pharma, Health, Chemistry, Biomaterials and Agrifood sectors.
Through Instruct, researchers can gain access to cutting-edge structural biology technologies whilst fostering collaborations with experts in their field. These collaborations and access visits can save huge costs in terms of training and investment in instrumentation.
Check out our list of structural biology services, technologies, and workflows offered to industry for proprietary research.
Instruct-ERIC has 27 facilties in 11 centres across Europe, offering more than 80 structural biology services for industry users.
Instruct organises events, training courses and webinars to advance expertise in structural biology for researchers and industry users.
A team from Janssen Vaccines & Prevention B.V collaborated with the Netherlands Center for Electron Nanoscopy (NeCEN) part of Instruct-NL to create and characterise new stable variants of the SARS-CoV-2 S trimer for vaccine development. Find out more.
Glaxo Smith Kline used NMR technology at the Instruct Centre in Florence, Italy, to determine the structure of some Neisseria meningitidis factor H-binding protein fHbp variants, towards identification of optimal antigens for vaccine development. Find out more
"The collaboration between our company and the Italian centre of Instruct-ERIC has been key for determining the structure-based antigen design against Neisseria meningitidis serogroup B using NMR spectroscopy. Thanks to the high-end NMR instruments and the expertise in structural biology available at CERM/CIRMMP, we have been able to deliver the first recombinant protein-based meningococcal vaccine targeting a challenging disease."
Ilaria Ferlenghi, GSK Vaccines, S.r.l.
"I was delighted to have access to the expertise and dedicated capabilities at the Instruct centre in Strasbourg, France. Thanks to this collaborative effort, we were able to describe the first molecular architecture of potassium chloride co-transporter KCC2. We have also collected high resolution data using their state-of-the-art facilities. We are confident that this work will enable structure-based drug discovery soon. This type of collaboration with Instruct is a game-changer and will be certainly duplicated for other highly druggable targets".
Anass Jawhari, CSO, CALIXAR
For price lists, cost information, or advice selecting which technology would answer your specific research question, please contact our Industry Liaison office using the contact form below.
